Literature DB >> 7796392

Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations.

M Oshima1, H Oshima, M Kobayashi, M Tsutsumi, M M Taketo.   

Abstract

Mutations in the adenomatous polyposis coli (APC) gene are responsible for not only familial adenomatous polyposis but also many sporadic cancers of the digestive tract. Most mutations found in familial adenomatous polyposis patients are of the truncation type, and the phenotype is affected by the mutation sites in the gene. Truncated APC proteins can associate with the wild-type protein. Accordingly, it has been proposed that the polyposis is caused by a dominant negative mechanism. To test this possibility, we constructed transgenic mice that contained mutant minigenes. They expressed the APC protein truncated either at codon 716 (Apc delta 716) or 1287 (Apc delta 1287) at high levels in the intestinal epithelium. Contrary to our expectation, no intestinal polyps or tumors were found in any of such mice, even after 7 months. These results rule out any dominant negative mechanisms in which the truncated APC protein is directly involved in the formation of intestinal polyps in the mouse.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796392

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein.

Authors:  W Friedl; S Meuschel; R Caspari; C Lamberti; S Krieger; M Sengteller; P Propping
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  Adenomatous polyposis coli (APC) is essential for maintaining the integrity of the seminiferous epithelium.

Authors:  Pradeep S Tanwar; Lihua Zhang; Jose M Teixeira
Journal:  Mol Endocrinol       Date:  2011-08-04

Review 3.  Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.

Authors:  Lu Zhang; Jerry W Shay
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

4.  PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression.

Authors:  Pradeep S Tanwar; Tomoko Kaneko-Tarui; Ho-Joon Lee; Lihua Zhang; Jose M Teixeira
Journal:  Carcinogenesis       Date:  2012-12-31       Impact factor: 4.944

5.  Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp).

Authors:  M R Bösl; K Takaku; M Oshima; S Nishimura; M M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

6.  Immunohistochemical detection of truncated APC protein in sporadic human colorectal adenomas and adenocarcinomas.

Authors:  S Akehi; S Murao; N Ueda; M Okujima; T Magaribuchi; S Saheki; H Nishimukai
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

Review 7.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

Review 8.  More than two decades of Apc modeling in rodents.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Biochim Biophys Acta       Date:  2013-01-17

Review 9.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

10.  Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo.

Authors:  Michael Buchert; Dimitris Athineos; Helen E Abud; Zoe D Burke; Maree C Faux; Michael S Samuel; Andrew G Jarnicki; Catherine E Winbanks; Ian P Newton; Valerie S Meniel; Hiromu Suzuki; Steven A Stacker; Inke S Näthke; David Tosh; Joerg Huelsken; Alan R Clarke; Joan K Heath; Owen J Sansom; Matthias Ernst
Journal:  PLoS Genet       Date:  2010-01-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.